Back to search
FDAFDA · Food and drugs·Recall number D-0619-2017

Atorvastatin Calcium Tablets, 20 mg*, packaged in a) 90-count bottles (NDC 0378-3951-09) and b) 500-count bottles (NDC 0378-3951-07); Rx only, Mylan Pharmaceuticals Inc., Morgantown, WV 26505 U.S.A.

Published April 5, 2017 · Recall initiated: March 20, 2017

Summary

FDA records drug Class II recall D-0619-2017, published April 5, 2017 and initiated March 20, 2017. Recalling firm: Mylan Pharmaceuticals Inc.; Status: Terminated; Reported quantity: 299,112 bottles; Lot: Lot #: a) 3073776, Exp 01/18; 3073777, 3074909, Exp 02/18; 3075564, 3075565, Exp 03/18; 2007338, Exp 08/18; b) 3070838, Exp 10/17; 3073775, Exp 01/18; 3074908, 3074909, Exp 02/18; 3075564, Exp 03/18; 2007224, 3075887, Exp 06/18; 2007337, 2007338, Exp 08/18. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Microbial Contamination of Non-Sterile Products: potential of an elevated bioburden with identification of objectionable organisms.

What to do

Voluntary: Firm initiated · Telephone

Get an email if ATORVASTATIN CALCIUM has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
ATORVASTATIN CALCIUM
Manufacturer
Mylan Pharmaceuticals Inc.
Distributor
Nationwide in the USA and Puerto Rico
UPC
0303783953779
Lot
Lot #: a) 3073776, Exp 01/18; 3073777, 3074909, Exp 02/18; 3075564, 3075565, Exp 03/18; 2007338, Exp 08/18; b) 3070838, Exp 10/17; 3073775, Exp 01/18; 3074908, 3074909, Exp 02/18; 3075564, Exp 03/18; 2007224, 3075887, Exp 06/18; 2007337, 2007338, Exp 08/18
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Atorvastatin Calcium Tablets, 20 mg*, packaged in a) 90-count bottles (NDC 0378-3951-09) and b) 500-count bottles (NDC 0378-3951-07); Rx only, Mylan Pharmaceuticals Inc., Morgantown, WV 26505 U.S.A. recalled?

Yes. FDA published recall D-0619-2017 on April 5, 2017. Reported hazard: Microbial Contamination of Non-Sterile Products: potential of an elevated bioburden with identification of objectionable organisms.

What should I do if I have this product?

Voluntary: Firm initiated · Telephone

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: ATORVASTATIN CALCIUM. UPC: 0303783953779.